Published in Hosp Pharm on January 01, 2015
Pharmacology and management of the vitamin K antagonists: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest (2008) 7.94
The effect of warfarin and intensity of anticoagulation on outcome of intracerebral hemorrhage. Arch Intern Med (2004) 3.63
National estimates of emergency department visits for hemorrhage-related adverse events from clopidogrel plus aspirin and from warfarin. Arch Intern Med (2010) 1.89
Risk-adjusted percent time in therapeutic range as a quality indicator for outpatient oral anticoagulation: results of the Veterans Affairs Study to Improve Anticoagulation (VARIA). Circ Cardiovasc Qual Outcomes (2010) 1.50
Warfarin: almost 60 years old and still causing problems. Br J Clin Pharmacol (2006) 1.50
A comparison of the efficacy and rate of response to oral and intravenous Vitamin K in reversal of over-anticoagulation with warfarin. Br J Haematol (2001) 1.17
The incidence of anaphylaxis following intravenous phytonadione (vitamin K1): a 5-year retrospective review. Ann Allergy Asthma Immunol (2002) 1.08
A retrospective evaluation of vitamin K1 therapy to reverse the anticoagulant effect of warfarin. Pharmacotherapy (2003) 0.95
Intravenous versus subcutaneous vitamin K1 in reversing excessive oral anticoagulation. Am J Cardiol (1999) 0.89
Evaluation of education on the appropriate use of vitamin k in warfarin reversal in adult inpatients. Hosp Pharm (2013) 0.87
A survey of oral vitamin K use by anticoagulation clinics. Arch Intern Med (2002) 0.83
Pharmacologic prophylaxis against venous thromboembolism in hospitalized patients with cirrhosis and associated coagulopathies. Am J Health Syst Pharm (2012) 0.81